You are here

Company Monitoring Page for Otsuka

latest headlines for company on cafepharma

FDA approves Otsuka/Lundbeck drug for both depression and schizophrenia

BioPharma Dive

Mon, 07/13/15 - 09:51 am

Tags:

FDA, Otsuka, Lundbeck, schizophrenia, Rexulta

FDA approves Otsuka and Lundbeck's schizophrenia treatment

Yahoo/Reuters

Fri, 07/10/15 - 10:53 pm

Tags:

FDA, Otsuka, Lundbeck, schizophrenia, Rexulti, antipsychotics

Bam! Bam! Two Plaintiffs Fall in Two District Court Decisions Concerning Orphan Drug Exclusivity Carve-Outs

FDA Law Blog

Fri, 05/29/15 - 10:23 am

Tags:

Otsuka, Abilify, orphan drugs, exclusivity, Fusilev, Spectrum Pharmaceuticals

Otsuka loses lawsuit challenging FDA approval of generic Abilify

Yahoo/Reuters

Thu, 05/28/15 - 02:00 pm

Tags:

Otsuka, FDA, Abilify, generics, Teva Pharmaceutical

It’s Been One of “Those Weeks” in Hatch-Waxman World: Another Two Lawsuits and Two Court Decisions

FDA Law Blog

Fri, 05/1/15 - 10:11 am

Tags:

FDA, Hatch Waxman Act, Spectrum Pharmaceuticals, Boehringer Ingelheim, Otsuka

Otsuka pulling out all the stops to deter copycats of blockbuster Abilify

BioPharma Dive

Fri, 04/17/15 - 10:36 am

Tags:

Otsuka, Abilify, Bristol-Myers Squibb

11 promising drugs poised to be the next billion-dollar blockbusters

Yahoo/Business Insider

Sat, 03/28/15 - 10:26 am

FDA is Sued by Otsuka for ‘Unlawfully’ Widening the Market for Abilify

WSJ Pharmalot

Thu, 03/26/15 - 09:30 pm

Tags:

FDA, Otsuka, Abilify, antipsychotics, generics

The top 10 patent losses of 2015

Fierce Pharma

Fri, 12/19/14 - 08:35 am

Tags:

patents, Lantus, Abilify, Copaxone, Neulasta, Tracleer, Namenda, Avodart, Jalyn, Zyvox, Androgel, Synagis, Sanofi, Bristol-Myers Squibb, Otsuka, Teva Pharmaceutical, Amgen, Actelion, Actavis, GSK, Pfizer, AbbVie, AstraZeneca

Drug makers face another $65 billion patent cliff

Marketwatch

Wed, 12/10/14 - 05:37 pm

Tags:

patents, patent cliff, Pfizer, Otsuka, AstraZeneca, Bristol-Myers Squibb

Otsuka May Have Undervalued Avanir’s (AVNR) Bid; Shareholders Worried

Bidness Etc.

Fri, 12/5/14 - 11:01 am

Tags:

Otsuka, M&A, Avanir

Japan’s Otsuka to buy U.S. drug maker Avanir for $3.5 billion

Fortune

Tue, 12/2/14 - 08:39 am

Tags:

Otsuka, M&A, Avanir

Bristol-Myers, Otsuka ask judge to nix Abilify kickback suit

Fierce Pharma

Mon, 10/13/14 - 10:26 am

Tags:

Bristol-Myers Squibb, Otsuka, kickbacks, Abilify, whistleblower lawsuits

TB Drug Fighting Resistant Strains Wins Europe Approval

Bloomberg

Wed, 04/30/14 - 08:59 am

Tags:

TB, Europe, Otsuka, Deltyba, tuberculosis

Otsuka Pharmaceutical Completes Acquisition of Astex Pharmaceuticals

Pharmiweb

Sat, 10/12/13 - 12:02 pm

Tags:

Otsuka, Astex, M&A

Lundbeck, Otsuka start trials for Alzheimer's drug

Reuters

Thu, 10/10/13 - 08:31 am

Tags:

Otsuka, Lundbeck, Alzheimer's disease, Lu AE58054

Biotech Buyout Celebration or Raw Deal?

Motley Fool

Sat, 10/5/13 - 09:55 am

Tags:

Astex, Otsuka, M&A

Astex Pharma shareholder opposes $886 mln bid by Otsuka

Yahoo/Reuters

Thu, 10/3/13 - 09:08 am

Tags:

Astex, Otsuka, shareholders, M&A

CHMP thumbs up for 11 new drugs

Pharma Times, UK

Mon, 09/23/13 - 09:33 am

Lundbeck, Otsuka get positive opinion for schizophrenia drug

Reuters

Fri, 09/20/13 - 09:42 am

Tags:

Otsuka, Lundbeck, Europe, schizophrenia, Abilify Maintena

Pages

last 30 twitter posts